Shingles :: New Vaccine to Reduce Older Americans’ Risk of Shingles
The Food and Drug Administration (FDA) licensed Zostavax, on May 25, 2006, a new vaccine to reduce the risk of shingles (herpes zoster) for use in people 60 years of age and older.
The Food and Drug Administration (FDA) licensed Zostavax, on May 25, 2006, a new vaccine to reduce the risk of shingles (herpes zoster) for use in people 60 years of age and older.
The U.S. Food and Drug Administration (FDA) has received a report that could help American industry and consumers take important steps to successfully combat the nation’s obesity problem. The report is titled, the “Keystone Forum on Away-From-Home Foods: Opportunities for Preventing Weight Gain and Obesity.” It provides recommendations from experts in industry, government, civic sector organizations, and academia, for improving consumers’ ability to manage calorie intake from foods prepared and purchased away-from-home. The Keystone Report offers recommendations related to: 1) understanding and influencing consumer behavior; 2) increasing the availability of lower-calorie products, menu items, and meals; and 3) providing consumers with nutrition information.
The Food and Drug Administration (FDA) today announced the tentative approval of generic abacavir (a-BAK-a-veer) sulfate tablets manufactured by Aurobindo Pharma LTD. of Hyderabad, India. Abacavir sulfate tablets are the first generic version of the already approved Ziagen Tablets, an anti-HIV medication manufactured by GlaxoSmithKline. This product will now be available for consideration for purchase under the President’s Emergency Plan for AIDS Relief.
US researchers have for the first time completed the analysis of the genes of a community of human microbes, which will have far-reaching implications for clinical diagnosis and treatment of many human diseases.
The Food and Drug Administration today approved Remicade (infliximab) to treat children with active Crohn’s disease, a chronic, inflammatory condition of the bowel that can be severely debilitating. Remicade is a genetically engineered monoclonal antibody, which reduces inflammation (swelling/redness) by blocking the action of tumor necrosis factor-alpha (TNF-a), that was initially approved in 1998 to treat Crohn’s disease in adults.
A vaccine that protects against the virus known to cause most cervical cancers was given the blessing of a U.S. Food and Drug Administration advisory panel Thursday.
1. – Sick headache, resulting from gastrohepatic derangement; dull, heavy, or throbbing headache, with vomiting of food and bile.
1. – Tongue trembles when protruded, or catches behind the teeth.
1. – Excessive fullness and distension of the abdomen, with flatulence, relieved by eructations.
1. – Acid dyspepsia; from milk, which sours; from cabbage, potatoes and other gross food.